A 61-year-old with T2DM and HFpEF is at glycaemic target on metformin alone. What cardiometabolic agent should be added to reduce HF hospitalisations?...

Question

A 61-year-old with T2DM and HFpEF is at glycaemic target on metformin alone. What cardiometabolic agent should be added to reduce HF hospitalisations?

Accepted Answer

SGLT2 inhibitor

Answer

DPP-4 inhibitor

Answer

GLP-1 receptor agonist only

Answer

Thiazolidinedione

Answer

Basal insulin

us-abim MCQ (SBA): HF and diabetes

A 61-year-old with T2DM and HFpEF is at glycaemic target on metformin alone. What cardiometabolic agent should be added to reduce HF hospitalisations?